Milne C. Jill's Insider Trades & SAST Disclosures

Milne C. Jill's most recent trade in Biocryst Pharmaceuticals Inc. was a trade of 26,684 Automatic Stock Option Grant done . Disclosure was reported to the exchange on Jan. 23, 2026.

Share

Note

This is a custom search result for pattern Milne C. Jill.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Biocryst Pharma Inc	Jill C. Milne	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2026	26,684	26,684	-		-	Automatic Stock Option Grant
Biocryst Pharma Inc	Jill C. Milne	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2026	12,272	14,854 (0%)	0%		0	Common Stock
Biocryst Pharma Inc	Jill C. Milne	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2026	2,582	2,582 (0%)	0%		-	Common Stock
Astria Therapeutics Inc	Jill C. Milne	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Mar 2025	761,000	761,000	-		-	Stock Option (Right to Buy)
Astria Therapeutics Inc	Milne C. Jill	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Feb 2024	534,600	534,600	-		-	Stock Option (Right to Buy)
Astria Therapeutics Inc	Jill C. Milne	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jun 2023	275,000	275,000	-		-	Stock Option (Right to Buy)
Astria Therapeutics Inc	Jill C. Milne	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2022	195,000	195,000	-		-	Stock Option (right to buy)
Astria Therapeutics Inc	Jill C. Milne	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jun 2021	1,400,000	1,400,000	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades